The Diploma of Advanced Studies (DAS) in Pharmaceutical Medicines program provides specialist knowledge in the field of drug development at an advanced level. The syllabus of the course program covers all aspects of pharmaceutical medicine and drug development as defined by the International Federation of Associations of Pharmaceutical Physicians (IFAPP, www.ifapp.org).
This includes the discovery and development of new medicines, clinical trial methodology, good clinical practice and ethics, pharmacovigilance and epidemiology, biostatistics, regulatory affairs, health economics, project management, marketing and new therapeutic approaches.
After having successfully completed the DAS program with 30 ECTS, training can be complemented with further learning elements to achieve a Master of Advanced Studies in Medicines Development.
The course program is divided into six modules consisting of four days each over a period of two years. Learning methods comprise online preparation, lectures and group work on case studies. The course language is English.
The ECPM Advanced Studies degrees are targeted at representatives from the pharmaceutical industry, service industry, academic and government decision- and policy-makers who already have a good understanding of the basics of drug development and will benefit from a more in-depth, comprehensive and systematic immersion into modern medical product and device development, regulation and market introduction.
Module Title |
Type |
Duration |
Credits |
CPD |
Global Drug Development and Pharmaceutical Business | Core | 4 days | 5.0 ECTS | No |
From Non-Clinical Testing to First-In-Humans | Core | 4 days | 5.0 ECTS | No |
Planning, Collecting and Managing Clinical Data | Core | 4 days | 5.0 ECTS | No |
Clinical and Safety Data Evaluation | Core | 4 days | 5.0 ECTS | No |
Global Registration and Approval Process | Core | 4 days | 5.0 ECTS | No |
Integrated Product Development, Healthcare Marketplace | Core | 4 days | 5.0 ECTS | No |